first of all I would have presented to the shareholder a buyout if there was one presented, or if it was in the price range above the then trading price of 34.00 I would have taken the buyout. It was obvious up to that point peter and his staff neither had the experience to go this alone.
If there was no buyout First of all I would not have taken a pay increase and if the market said the drug was too expensive, Selling at a smaller profit and reaching a greater number of patients would be the first priority.
Second I would have looked at all the dead weight and over paid management/employees and cut staff because obviously those there were/and those there now are not performing up to the needs of the company.
you can scoff at me all you want, I am not happy about being correct about peters ability to run this company. He once stated shareholder value and getting the drug to as many as needed it as possible. so far he has done neither.
The share price never should have fallen below the price it was after FDA approval, that is all on management.
you can continue to stand up for perter all you want and that just makes him pleased ap punch, fact to date show that peter only cares about peter and his over paid salary proves.
He cannot even get the sales high enough for the company to pay it's own way and when the slush fund runs out so does all of our value.
We would be lucky to get a 10-15 dollar buyout offer right now, and if we could get that high I would run and never look back.
I am sure you of all shareholders is just tickled to be down 30.00 a share.
